We are independent & ad-supported. We may earn a commission for purchases made through our links.
Advertiser Disclosure
Our website is an independent, advertising-supported platform. We provide our content free of charge to our readers, and to keep it that way, we rely on revenue generated through advertisements and affiliate partnerships. This means that when you click on certain links on our site and make a purchase, we may earn a commission. Learn more.
How We Make Money
We sustain our operations through affiliate commissions and advertising. If you click on an affiliate link and make a purchase, we may receive a commission from the merchant at no additional cost to you. We also display advertisements on our website, which help generate revenue to support our work and keep our content free for readers. Our editorial team operates independently of our advertising and affiliate partnerships to ensure that our content remains unbiased and focused on providing you with the best information and recommendations based on thorough research and honest evaluations. To remain transparent, we’ve provided a list of our current affiliate partners here.
Conditions

Our Promise to you

Founded in 2002, our company has been a trusted resource for readers seeking informative and engaging content. Our dedication to quality remains unwavering—and will never change. We follow a strict editorial policy, ensuring that our content is authored by highly qualified professionals and edited by subject matter experts. This guarantees that everything we publish is objective, accurate, and trustworthy.

Over the years, we've refined our approach to cover a wide range of topics, providing readers with reliable and practical advice to enhance their knowledge and skills. That's why millions of readers turn to us each year. Join us in celebrating the joy of learning, guided by standards you can trust.

What are Amyloid Fibrils?

By Melissa Foltz
Updated: Mar 03, 2024
Views: 23,585
Share

Amyloid fibrils are thread-like protein aggregates that are insoluble and resistant to protease activity. Depending on the protein making up the fibrils, amyloid structures can accumulate at different sites in the body, including the brain, joints and pancreas. Extensive genetic, pathological and biochemical evidence indicates that the accumulation of amyloid fibrils in tissues is involved in numerous diseases, including Alzheimer’s, Parkinson’s, type 2 diabetes and prion disease. For example, the brains of Alzheimer’s patients show plaques of amyloid fibrils formed from beta-amyloid protein.

Approximately 30 proteins form amyloid fibrils in humans; they are not related and do not share a common structure or sequence similarity. All of them, however, are folded in a manner that differs from normal protein folding patterns, with the same structure always found at the core of a fibril. Proteins that form amyloid fibrils in human diseases include immunoglobulin light chains, gelsolin, procalcitonin, beta-amyloid protein, serum amyloid A protein, beta 2-microglobulin, transthyretin and prion protein.

Regardless of the proteins involved, amyloid fibrils have characteristic structural properties, particularly their cross-beta-sheet quaternary structure. Single proteins build into long filaments that link side-by-side into ribbons. These stacks of beta-sheets, tightly connected by hydrogen bonds, run perpendicular to the fibril's long axis.

This distinctive structure might result from the strong charge carried by the fibrils’ building blocks. Proteins with glutamine-rich sequences are important in the prion diseases and Huntington's disease. The glutamines can brace the beta-sheet structure by forming intrastrand hydrogen bonds between the amide carbonyls and nitrogens. In other proteins, such as the Alzheimer's-associated beta-ameloid protein, hydrophobic association is thought to hold the structure together.

Amyloid fibrils are a result of problems in protein self-assembly and appear to be a result of the aging process. The vast majority of diseases caused by amyloid structures are found in elderly patients. It was once believed that ameloid fibrils are inert, with cell-damaging toxic intermediates during their formation causing the cell damage. Research has shown, however, that the fibers themselves are actually toxic, particularly when fragmented into shorter pieces. It is not known exactly how the fibers are toxic to cells or why the shorter fibers are more toxic, but one possibility is that their small size makes it easier to enter cells.

These fibrils have a characteristic straight, unbranching appearance when observed by electron microscopy. They are usually identified indirectly using fluorescent dyes, stain polarimetry, circular dichroism or Fourier transform infrared spectroscopy. An X-ray diffraction analysis can be used to directly determine the presence of the cross-beta spine structure by characteristic scattering diffraction signals.

Share
The Health Board is dedicated to providing accurate and trustworthy information. We carefully select reputable sources and employ a rigorous fact-checking process to maintain the highest standards. To learn more about our commitment to accuracy, read our editorial process.
Discussion Comments
By Melonlity — On Apr 05, 2014

@Terrificli -- another problem with amyloid fibrils in general is that one of the most effective ways to curb them is through chemotherapy. One of the few things we do know is that amyloid fibrils develop in the elderly, and chemotherapy is taxing for even someone who is youthful and better able to recover from the effects of that treatment.

In a number of cases, the chemotherapy becomes as dangerous as the condition that has developed in response to the formation of amyloid fibrils. That's the very definition of being caught between a rock and a hard place, isn't it?

By Terrificli — On Apr 04, 2014

What is particularly disturbing about amyloid fibrils is that there are a lot of theories about why they form but few effective treatment regimens. The treatment of amyloid fibrils that can lead to a number of very serious conditions is typically left up to experts in the field and there are precious few of them in the United States or anywhere else for that matter.

To complicate things further, it is not always easy to determine that amyloid fibrils are at the root of conditions. For example, amyloidosis is a condition where the fibrils form and restrict the normal operation of vital organs. If that organ is, say, the heart then a doctor might diagnose the patient as having a very common heart condition rather than the very rare and much more dangerous amyloidosis. The patient could be treated for a heart condition rather than amyloidosis for awhile and lose valuable time that could be used to curb the cause of the problem.

Share
https://www.thehealthboard.com/what-are-amyloid-fibrils.htm
Copy this link
The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.

The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.